“…The first approach consisted in the use of [1,2,3]triazolylpropyl connector generated by 1,3‐dipolar cycloaddition, in the presence of CuSO 4 ⋅ 5 H 2 O and sodium ascorbate, giving hybrids 5 , 6 , 11 , and 12 in good yield (69–78 % after purification). The intermediate carboranylazides ( 3 , 4 , 9 , and 10 ) were selected to introduce chemodiversity to the final compounds, that is, un‐substituted and methyl‐substituted 1,2‐ and 1,7‐ closo ‐carboranyl frameworks. The second approach involved the transformation of ethynyl‐erlotinib group into an erlotinib‐ethynylbenzyl connector (Scheme ), via Sonogashira cross‐coupling in presence of CuI and [PdCl 2 (PPh 3 ) 2 ], generating compounds 15 , 16 , 19 , and 20 in 35–49 % yield, after purification.…”